Background Prophylactic administration of mesenchymal stromal cells (MSC s) derived from
adipose (AD‐MSC) and bone marrow tissue (BM‐MSC) in ovalbumin‐induced asthma …

Autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs) are evaluated for
clinical use in chronic obstructive pulmonary disease (COPD) patients, but it is unclear …

Background COPD is a pulmonary disorder often accompanied by cardiovascular disease
(CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in …

Mesenchymal stem (stromal) cells (MSCs) are multipotent stromal cells that have the ability
to modulate immune response to tissue injury and promote repair in vivo. The therapeutic …

Sarcoidosis is a devastating inflammatory disease affecting many organs, especially the
lungs and lymph nodes. Bone marrow-derived mesenchymal stromal cells (MSCs) can …

Due to their anti-inflammatory, antiapoptotic, antimicrobial, and antifibrotic properties,
mesenchymal stromal cells (MSCs) have been considered a promising alternative for …

Paracrine factors are currently considered to be the major mechanism through which
mesenchymal stem cells (MSCs) exert their actions. The aim of this study was to investigate …

Interstitial lung disease (ILD) increases morbidity and mortality in patients with rheumatoid
arthritis (RA). Although the pathogenesis of ILD associated with RA (RA-ILD+) remains …

Acute respiratory distress syndrome (ARDS) is an important cause of morbidity and mortality,
with no currently effective therapies. Several preclinical studies have shown that human …

Thymic stromal lymphopoietin (TSLP) recently has emerged as a key cytokine in the
development of type 2 immune responses. Although traditionally associated with allergic …